1
|
Ciotti E, Catalani F, Martino F, Camplone I, Valisella C, Petroni M, Randazzo C. An individual care plan for a high risk elderly population in the Local Health Authority of Bologna. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa166.1266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Issue
Fragility is a major challenge that demand a comprehensive public health response, since a high rate of population is aging and becoming vulnerable.
Description of the Problem
The Local Health Authority of Bologna, about 850,000 inhabitants, has implemented a new qualitative and quantitative Project on fragile patients. Frailty was measured by the “Risk Profile of the Emilia-Romagna region,”, an algorithm that provides a risk index, based on patients'record, which divide population in risk categories (high/very high, moderate and low risk) of hospitalization. The 585 General Practitioners (GPs) have enrolled their fragile patients with high and very high risk (about 6% of the population). GPs and other healthcare professionals are asked to define an Individualized Care Plan (ICP) according to an integrated and multi-professional management perspective. Patients' and healthcare professionals' subjective experience was collected throughout a structured interview.
Results
From October 2018 to April 2019, 260 patients were included in the project and they received a ICP which included different interventions such as: integrated nursing care (105), nursing care in chronic ambulatory (55), community hospital care (9), social assistance (92), physiotherapy (88), specialist activities (114). Qualitative data highlighted high level of satisfaction both in patients and clinicians. The strengths of the Project are: 1) an integrated management (with a multi- professional team) of frailty population, 2) proactive and individualized treatment plan. Limitations are: 1) different approaches among clinicians in the Local Health Authority of Bologna with possible inequalities of accessibility to the treatment; 2) difficulties in the relationships among clinicians.
The early recognition and the specialistic management of the fragile population have to be considered a priority in health practice in order to provide effective medical intervention.
Key messages
Individualized Care Plan (ICP) and integrated and multi-professional management. Importance of fragility early recognition.
Collapse
Affiliation(s)
| | - F Catalani
- School of Hygiene and Preventive Medicine, University, Bologna, Italy
| | | | | | | | | | | |
Collapse
|
2
|
Coppa A, Valentini V, Nicolussi A, Capalbo C, Belardinilli F, Colicchia V, Petroni M, D’Inzeo S, Ottini L, Giannini G. PO-076 Molecular analysis of BRCA-negative breast and/or ovarian cancer families by multigene panel testing. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
3
|
Colicchia V, Petroni M, Guarguaglini G, Sardina F, Sahún-Roncero M, Carbonari M, Ricci B, Heil C, Capalbo C, Belardinilli F, Coppa A, Peruzzi G, Screpanti I, Lavia P, Gulino A, Giannini G. PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma. Oncogene 2017; 36:4682-4691. [PMID: 28394338 DOI: 10.1038/onc.2017.40] [Citation(s) in RCA: 60] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2016] [Revised: 12/05/2016] [Accepted: 01/11/2017] [Indexed: 12/18/2022]
Abstract
High-risk and MYCN-amplified neuroblastomas are among the most aggressive pediatric tumors. Despite intense multimodality therapies, about 50% of these patients succumb to their disease, making the search for effective therapies an absolute priority. Due to the important functions of poly (ADP-ribose) polymerases, PARP inhibitors have entered the clinical settings for cancer treatment and are being exploited in a variety of preclinical studies and clinical trials. PARP inhibitors based combination schemes have also been tested in neuroblastoma preclinical models with encouraging results. However, the expression of PARP enzymes in human neuroblastoma and the biological consequences of their inhibition remained largely unexplored. Here, we show that high PARP1 and PARP2 expression is significantly associated with high-risk neuroblastoma cases and poor survival, highlighting its previously unrecognized prognostic value for human neuroblastoma. In vitro, PARP1 and 2 are abundant in MYCN amplified and MYCN-overexpressing cells. In this context, PARP inhibitors with high 'PARP trapping' potency, such as olaparib or talazoparib, yield DNA damage and cell death preceded by intense signs of replication stress. Notwithstanding the activation of a CHK1-CDC25A replication stress response, PARP-inhibited MYCN amplified and overexpressing cells fail to sustain a prolonged checkpoint and progress through mitosis in the presence of damaged DNA, eventually undergoing mitotic catastrophe. CHK1-targeted inhibition of the replication stress checkpoint exacerbated this phenotype. These data highlight a novel route for cell death induction by PARP inhibitors and support their introduction, together with CHK1 inhibitors, in therapeutic approaches for neuroblastomas with high MYC(N) activity.
Collapse
Affiliation(s)
- V Colicchia
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - M Petroni
- Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy
| | - G Guarguaglini
- Institute of Molecular Biology and Pathology, CNR National Research Council, c/o University La Sapienza, Rome, Italy
| | - F Sardina
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - M Sahún-Roncero
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - M Carbonari
- Department of Clinical Medicine, University La Sapienza, Rome, Italy
| | - B Ricci
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - C Heil
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - C Capalbo
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - F Belardinilli
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - A Coppa
- Department of Experimental Medicine, University La Sapienza, Rome, Italy
| | - G Peruzzi
- Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy
| | - I Screpanti
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - P Lavia
- Institute of Molecular Biology and Pathology, CNR National Research Council, c/o University La Sapienza, Rome, Italy
| | - A Gulino
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - G Giannini
- Department of Molecular Medicine, University La Sapienza, Rome, Italy.,Istituto Pasteur-Fondazione Cenci Bolognetti, Department of Molecular Medicine, University La Sapienza, Rome, Italy
| |
Collapse
|
4
|
Petroni M, Sardina F, Roncero MS, Heil C, Infante P, Ricci B, Petricci E, Locatelli E, Comes-Franchini M, Giannini G. The MRN complex: A potential target for MYCN amplified neuroblastoma. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)61479-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
5
|
Petroni M, Sardina F, Heil C, Sahún-Roncero M, Colicchia V, Veschi V, Albini S, Fruci D, Ricci B, Soriani A, Di Marcotullio L, Screpanti I, Gulino A, Giannini G. The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress. Cell Death Differ 2016; 23:197-206. [PMID: 26068589 PMCID: PMC4716299 DOI: 10.1038/cdd.2015.81] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2014] [Revised: 04/12/2015] [Accepted: 05/18/2015] [Indexed: 12/27/2022] Open
Abstract
The MRE11/RAD50/NBS1 (MRN) complex is a major sensor of DNA double strand breaks, whose role in controlling faithful DNA replication and preventing replication stress is also emerging. Inactivation of the MRN complex invariably leads to developmental and/or degenerative neuronal defects, the pathogenesis of which still remains poorly understood. In particular, NBS1 gene mutations are associated with microcephaly and strongly impaired cerebellar development, both in humans and in the mouse model. These phenotypes strikingly overlap those induced by inactivation of MYCN, an essential promoter of the expansion of neuronal stem and progenitor cells, suggesting that MYCN and the MRN complex might be connected on a unique pathway essential for the safe expansion of neuronal cells. Here, we show that MYCN transcriptionally controls the expression of each component of the MRN complex. By genetic and pharmacological inhibition of the MRN complex in a MYCN overexpression model and in the more physiological context of the Hedgehog-dependent expansion of primary cerebellar granule progenitor cells, we also show that the MRN complex is required for MYCN-dependent proliferation. Indeed, its inhibition resulted in DNA damage, activation of a DNA damage response, and cell death in a MYCN- and replication-dependent manner. Our data indicate the MRN complex is essential to restrain MYCN-induced replication stress during neural cell proliferation and support the hypothesis that replication-born DNA damage is responsible for the neuronal defects associated with MRN dysfunctions.
Collapse
Affiliation(s)
- M Petroni
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - F Sardina
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - C Heil
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - M Sahún-Roncero
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - V Colicchia
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - V Veschi
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - S Albini
- Paediatric Haematology/Oncology Department, IRCCS, Ospedale Pediatrico Bambino Gesù, 00165 Rome, Italy
| | - D Fruci
- Paediatric Haematology/Oncology Department, IRCCS, Ospedale Pediatrico Bambino Gesù, 00165 Rome, Italy
| | - B Ricci
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - A Soriani
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - L Di Marcotullio
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - I Screpanti
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - A Gulino
- Department Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| | - G Giannini
- Istituto Pasteur-Fondazione Cenci Bolognetti, Deptartment of Molecular Medicine, University La Sapienza, 00161 Rome, Italy
| |
Collapse
|
6
|
Veschi V, Petroni M, Bartolazzi A, Altavista P, Dominici C, Capalbo C, Boldrini R, Castellano A, McDowell HP, Pizer B, Frati L, Screpanti I, Gulino A, Giannini G. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors. Cell Death Dis 2014; 5:e1100. [PMID: 24603328 PMCID: PMC3973198 DOI: 10.1038/cddis.2014.68] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2013] [Revised: 01/16/2014] [Accepted: 01/22/2014] [Indexed: 01/03/2023]
Abstract
Childhood neuroblastic tumors are characterized by heterogeneous clinical courses, ranging from benign ganglioneuroma (GN) to highly lethal neuroblastoma (NB). Although a refined prognostic evaluation and risk stratification of each tumor patient is becoming increasingly essential to personalize treatment options, currently only few biomolecular markers (essentially MYCN amplification, chromosome 11q status and DNA ploidy) are validated for this purpose in neuroblastic tumors. Here we report that Galectin-3 (Gal-3), a β-galactoside-binding lectin involved in multiple biological functions that has already acquired diagnostic relevance in specific clinical settings, is variably expressed in most differentiated and less aggressive neuroblastic tumors, such as GN and ganglioneuroblastoma, as well as in a subset of NB cases. Gal-3 expression is associated with the INPC histopathological categorization (P<0.001) and Shimada favorable phenotype (P=0.001), but not with other prognostically relevant features. Importantly, Gal-3 expression was associated with a better 5-year overall survival (P=0.003), and with improved cumulative survival in patient subsets at worse prognosis, such as older age at diagnosis, advanced stages or NB histopathological classification. In vitro, Gal-3 expression and nuclear accumulation accompanied retinoic acid-induced cell differentiation in NB cell lines. Forced Gal-3 overexpression increased phenotypic differentiation and substrate adherence, while inhibiting proliferation. Altogether, these findings suggest that Gal-3 is a biologically relevant player for neuroblastic tumors, whose determination by conventional immunohistochemistry might be used for outcome assessment and patient's risk stratification in the clinical setting.
Collapse
Affiliation(s)
- V Veschi
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - M Petroni
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - A Bartolazzi
- 1] Department of Pathology, St. Andrea Hospital, Rome, Italy [2] Pathology Research Laboratory, Cancer Center Karolinska (CCK), Karolinska Hospital, Stockholm, Sweden
| | - P Altavista
- Unit of Radiation Biology and Human Health, Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Research Center Casaccia, Rome, Italy
| | - C Dominici
- 1] Department of Pediatrics and Infantile Neuropsychiatry, University La Sapienza, Rome, Italy [2] School of Reproductive and Developmental Medicine, Liverpool University, Liverpool, UK
| | - C Capalbo
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - R Boldrini
- Division of Pathology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - A Castellano
- Division of Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - H P McDowell
- 1] Department of Pediatrics and Infantile Neuropsychiatry, University La Sapienza, Rome, Italy [2] School of Reproductive and Developmental Medicine, Liverpool University, Liverpool, UK
| | - B Pizer
- Department of Oncology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - L Frati
- Department of Experimental Medicine, University La Sapienza, Rome, Italy
| | - I Screpanti
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - A Gulino
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| | - G Giannini
- Department of Molecular Medicine, University La Sapienza, Rome, Italy
| |
Collapse
|
7
|
Jung SH, Saxena A, Kaur K, Fletcher E, Ponemone V, Nottingham JM, Sheppe JA, Petroni M, Greene J, Graves K, Baliga MS, Fayad R. The role of adipose tissue-associated macrophages and T lymphocytes in the pathogenesis of inflammatory bowel disease. Cytokine 2012; 61:459-68. [PMID: 23245845 DOI: 10.1016/j.cyto.2012.11.021] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2012] [Revised: 10/24/2012] [Accepted: 11/20/2012] [Indexed: 12/24/2022]
Abstract
Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders of the gastrointestinal tract that affect more than 3 million people worldwide, but the pathological etiology is still unknown. The overall purpose of our investigations was to elucidate the possibility of pathological causes of IBD, and therefore, we determined the difference of inflammatory cytokine profiles in adipose tissue macrophages (ATMs) and T lymphocytes (ATTs) obtained near active lesions of IBD; investigated whether the alteration in ATM activation induces genes involved in collagen formation; and evaluated the effects of fatty acid oxidation inhibitors on factors involved in inflammation and collagen production by ATMs in IBD. Adipose tissues (ATs) were collected near active lesions and also at the margin of resected segments of the bowel from IBD patients with ulcerative colitis (UC) and CD (n=14/group). Normal appearing ATs from control subjects (n=14) who had colon resection for adenocarcinoma were collected as far away from the cancer lesion as possible to rule out possible changes. Compared with inactive disease lesions, ATMs and ATTs from active lesions released more IL-6, IL-4 and IL-13. Treatments of cytokine IL-4 and/or IL-13 to ATMs reduced iNOS expression but increased Arg-I expression which were exacerbated when treated with T cell- and adipocyte-conditioned medium. However, fatty acid oxidation inhibitors prevented the effects of cytokines IL-4 and/or IL-13 on iNOS and Arg-I expressions. This study was the first to show the effect of IL-4 and IL-13 on collagen formation, through iNOS and Arg-I expressions, that was exacerbated in a condition that mimics in vivo condition of active lesions. Moreover, our study was the first to provide potential benefits of fatty acid oxidation inhibitors to ATMs on preventing collagen formation; thus, providing therapeutic implications for individuals with intestinal fibrosis and stricture lesions, although future study should be guaranteed to elucidate the underlying mechanisms.
Collapse
Affiliation(s)
- Seung Ho Jung
- Department of Pharmacology, Physiology & Neuroscience, School of Medicine, University of South Carolina, Columbia, SC 29208, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Panebianco V, Grazhdani H, Iafrate F, Petroni M, Anzidei M, Laghi A, Passariello R. 3D CT protocol in the assessment of the esophageal neoplastic lesions: can it improve TNM staging? Eur Radiol 2005; 16:414-21. [PMID: 16041528 DOI: 10.1007/s00330-005-2851-5] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2005] [Revised: 05/25/2004] [Accepted: 06/21/2005] [Indexed: 12/01/2022]
Abstract
The purpose of this prospective observational study was the evaluation of the usefulness of MPR reconstructions and virtual endoscopy in the study of the esophageal carcinoma. Thirty-nine patients with esophageal cancer proved by means of endoscopy, underwent preoperative TNM staging with dynamic CT of the chest and abdomen with the aid of 3D rendering. Twenty-six patients underwent surgery, and the CT results were compared with histopathologic findings. In staging the T parameter, the CT with 3D reconstructions and virtual endoscopy, showed a sensitivity of 92% and an accuracy of 88%. In staging lymph nodes, the sensitivity in our study was 85%, the specificity 58%, and the accuracy 69%. Our protocol of the study of the esophageal cancer with 3D CT and virtual endoscopy, demonstrated a high concordance with the surgical and pathologic findings. The 3D reconstructed images were very helpful to the surgeons regarding preoperative planning. We performed an observational enquiry, and although this was a small study, it has, however, confirmed that the 3D imaging of the esophagus represents a valuable advantage to conventional imaging. Further studies with a larger number of patients are needed to prove its superiority to traditional CT imaging of the esophagus.
Collapse
Affiliation(s)
- V Panebianco
- Department of Radiological Sciences, University of Rome La Sapienza, Viale del Policlinico 155, 00161, Rome, Italy.
| | | | | | | | | | | | | |
Collapse
|
9
|
Abstract
Fetal inguinal hernia is a rare antenatal diagnosis. We present the sonographic features and outcome of a fetus diagnosed at 36 weeks' gestation as having an (indirect) inguinoscrotal hernia. Sonographic criteria for antenatal diagnosis are discussed within the context of differential diagnoses raised by the presence of a perineal mass. Guidelines for obstetric management and counselling are suggested.
Collapse
Affiliation(s)
- G Kesby
- Alan Bradfield Fetal Medicine Unit, Division of Women's and Children's Health, Royal Prince Alfred Hospital, Sydney, Australia
| | | | | |
Collapse
|
10
|
Murphy TV, Clements JF, Petroni M, Coury S, Stetler L. Haemophilus influenzae type b in respiratory secretions. Pediatr Infect Dis J 1989; 8:148-51. [PMID: 2785262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Oral and respiratory secretions of 31 children who were healthy or had mild upper respiratory infection, and who had a positive throat culture for Haemophilus influenzae type b, were cultured to determine which secretions contain this organism and how long it can be recovered from fomites. Rhinorrhea was present in 11 of 31 (34%) children and nasal mucus was positive for H. influenzae type b in 10 (91%). In 5 of these children the concentration of H. influenzae type b in nasal mucus was 10(4) to 10(7) colony-forming units/ml3. H. influenzae type b in nasal mucus applied to fomites were recovered for 12 hours. Cultures of saliva and cough secretions compared with nasal mucus were less often positive (3 of 31, P less than 0.001; 3 of 25, P less than 0.001, respectively) and contained fewer H. influenzae type b (5 and 15 colony-forming units, respectively). H. influenzae type b was recovered from the hand of 2 of 27 (7%) children; both children had positive cultures of saliva. These data indicate that H. influenzae type b can be found in oral and respiratory secretions of pharyngeal carriers and can contaminate children's hands. Nasal mucus was the most consistently positive secretion and contained the largest number of bacteria. Careful management of nasal mucus secretions is warranted in settings where transmission could occur to susceptible children.
Collapse
Affiliation(s)
- T V Murphy
- Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas
| | | | | | | | | |
Collapse
|